זימקסיד
Country: Iżrael
Lingwa: Ebrajk
Sors: Ministry of Health
Xi dokumenti għal dan il-prodott mhumiex disponibbli bħalissa, tista 'tibgħat talba lis-servizz tal-konsumatur tagħna u aħna ninnotifikawkom malli nkunu nistgħu niksbuhom.
Ibgħat talba.
Ibgħat talba.
Ingredjent attiv:
GATIFLOXACIN 0.5 %W/V
Disponibbli minn:
ALLERGAN ISRAEL LTD
Kodiċi ATC:
S01AX21
Għamla farmaċewtika:
OPHTHALMIC SOLUTION
Rotta amministrattiva:
OCULAR
Manifatturat minn:
ALLERGAN INC., USA
Grupp terapewtiku:
GATIFLOXACIN
Indikazzjonijiet terapewtiċi:
Zymaxid is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms: Aerobic Gram- Negative Bacteria : Haemophilus influenzae, Aerobic Gram-positive Bacteria: Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus mitis group*, Streptococcus oralis *, Streptococcus pneumoniae. Efficacy for this organisms was studied in fewer than 10 infections.
Data ta 'l-awtorizzazzjoni:
2012-11-01
